Production booster from Navin Fluorine

| Updated on January 07, 2020 Published on January 07, 2020

Navin Fluorine International on Tuesday said it has commenced commercial production at Dewas, Madhya Pradesh, from January 6, to create additional cGMP capacity. The Dewas facility is the hub of its CRAMS activities. In December, the board of Navin had approved a capital expenditure programme at Dahej (Gujarat) through a wholly-owned subsidiary at an estimated capital outlay of ₹450 crore over the next three-four years. Investors will closely monitor developments.

Published on January 07, 2020
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.